Frailty: A phenotype under review;Fragilidad: Un fenotipo en revisión

Gaceta Sanitaria

Volumn 25, Issue SUPPL. 2, 2011, Pages 51-58

  García García, Francisco José ^a   Larrión Zugasti, José Luis ^b   Rodríguez Mañas, Leocadio ^c  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b Universidad Pública de Navarra   (Spain)

^c HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Aging; Frailty; Inflammation; Life styles; Obesity; Sarcopenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NITRIC OXIDE;

AGED; AGING; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; FRAIL ELDERLY; HUMAN; INFLAMMATION; LIFESTYLE; MUSCLE ATROPHY; OBESITY; PHENOTYPE; PHYSIOLOGY; RISK; SEDENTARY LIFESTYLE; STATISTICS; VASCULAR DISEASE;

AGED; AGING; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM DISEASES; CHRONIC DISEASE; FRAIL ELDERLY; HUMANS; INFLAMMATION; LIFE STYLE; NITRIC OXIDE; OBESITY; PHENOTYPE; RISK; SARCOPENIA; SEDENTARY LIFESTYLE; VASCULAR DISEASES;

EID: 84856499835     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1016/j.gaceta.2011.08.001     Document Type: Article

References (99)

1. Magnussen C.G., Koskinen J., Chen W., et al. Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus, but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. Circulation 2010, 122:1604-1611.
2. Khaw K.T., Wareham N., Bingham S., et al. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med 2008, 5:e12.
3. Vaillant G.E., Mukamal K. Successful aging. Am J Psychiatry 2001, 158:839-847.
4. Bergman H., Ferrucci L., Guralnik J., et al. Frailty: an emerging research and clinical paradigm - issues and controversies. J Gerontol A Biol Sci Med Sci 2007, 62:731-737.
5. Rockwood K., Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 2011, 27:17-26.
6. Song X., Mitnitski A., Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc 2010, 58:681-687.
7. Walston J., Fried L.P. Frailty and the older man. Med Clin North Am 1999, 83:1173-1194.
8. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-M156.
9. Xue Q.L. The frailty syndrome: definition and natural history. Clin Geriatr Med 2011, 27:1-15.
10. García-García FJ GAG, Alfaro Acha A, et al. The prevalence of frailty syndrome in an older population from Spain. The Toledo Study for Healthy Aging. JNHA. 2011. DOI: 10.1007/S12603-011-0075-8.
11. Abizanda Soler P., López-Torres Hidalgo J., Romero Rizos L., et al. [Frailty and dependence in Albacete (FRADEA study): reasoning, design and methodology.]. Rev Esp Geriatr Gerontol 2011, 46:81-88.
12. Alcalá M.V., Puime A.O., Santos M.T., et al. [Prevalence of frailty in an elderly Spanish urban population. Relationship with comorbidity and disability]. Aten Primaria 2010, 42:520-527.
13. Santos-Eggimann B., Cuenoud P., Spagnoli J., et al. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci 2009, 64:675-681.
14. Alvarado B.E., Zunzunegui M.V., Beland F., et al. Life course social and health conditions linked to frailty in Latin American older men and women. J Gerontol A Biol Sci Med Sci 2008, 63:1399-1406.
15. Woods N.F., LaCroix A.Z., Gray S.L., et al. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc 2005, 53:1321-1330.
16. Ottenbacher K.J., Graham J.E., Al Snih S., et al. Mexican Americans and frailty: findings from the Hispanic established populations epidemiologic studies of the elderly. Am J Public Health 2009, 99:673-679.
17. Ensrud K.E., Ewing S.K., Cawthon P.M., et al. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc 2009, 57:492-498.
18. Avila-Funes J.A., Helmer C., Amieva H., et al. Frailty among community-dwelling elderly people in France: the three-city study. J Gerontol A Biol Sci Med Sci 2008, 63:1089-1096.
19. Afilalo J., Karunananthan S., Eisenberg M.J., et al. Role of frailty in patients with cardiovascular disease. Am J Cardiol 2009, 103:1616-1621.
20. Gill T.M., Gahbauer E.A., Allore H.G., et al. Transitions between frailty states among community-living older persons. Arch Intern Med 2006, 166:418-423.
21. Gruenewald T.L., Seeman T.E., Karlamangla A.S., et al. Allostatic load and frailty in older adults. J Am Geriatr Soc 2009, 57:1525-1531.
22. Doherty T.J. Invited review: aging and sarcopenia. J Appl Physiol 2003, 95:1717-1727.
23. Puts M.T., Visser M., Twisk J.W., et al. Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf) 2005, 63:403-411.
24. Barzilay J.I., Blaum C., Moore T., et al. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 2007, 167:635-641.
25. Leng S.X., Xue Q.L., Tian J., et al. Inflammation and frailty in older women. J Am Geriatr Soc 2007, 55:864-871.
26. Payette H., Roubenoff R., Jacques P.F., et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J Am Geriatr Soc 2003, 51:1237-1243.
27. Hyde Z., Flicker L., Almeida O.P., et al. Low free testosterone predicts frailty in older men: the health in men study. J Clin Endocrinol Metab 2010, 95:3165-3172.
28. Voznesensky M., Walsh S., Dauser D., et al. The association between dehydroepiandosterone and frailty in older men and women. Age Ageing 2009, 38:401-406.
29. Hubbard R.E., Lang I.A., Llewellyn D.J., et al. Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci 2010, 65:377-381.
30. Zamboni M., Mazzali G., Fantin F., et al. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 2008, 18:388-395.
31. Stenholm S., Harris T.B., Rantanen T., et al. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008, 11:693-700.
32. Wang X., Hu Z., Hu J., et al. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006, 147:4160-4168.
33. Wilhelm-Leen E.R., Hall Y.N., Deboer I.H., et al. Vitamin D deficiency and frailty in older Americans. J Intern Med 2010, 268:171-180.
34. Hubbard R.E., O'Mahony M.S., Calver B.L., et al. Nutrition, inflammation, and leptin levels in aging and frailty. J Am Geriatr Soc 2008, 56:279-284.
35. Jackson A.S., Sui X., Hebert J.R., et al. Role of lifestyle and aging on the longitudinal change in cardiorespiratory fitness. Arch Intern Med 2009, 169:1781-1787.
36. Barlow C.E., Kohl H.W., Gibbons L.W., et al. Physical fitness, mortality and obesity. Int J Obes Relat Metab Disord 1995, 19(Suppl 4):S41-S44.
37. Baumgartner R.N., Koehler K.M., Gallagher D., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998, 147:755-763.
38. Danaei G.D., Mozaffarian D., Taylor B., et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009, 6:58-60.
39. Knoops K.T., de Groot L.C., Kromhout D., et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004, 292:1433-1439.
40. Powell K.E., Blair S.N. The public health burdens of sedentary living habits: theoretical but realistic estimates. Med Sci Sports Exerc 1994, 26:851-856.
41. Thijssen D.H., Maiorana A.J., O'Driscoll G., et al. Impact of inactivity and exercise on the vasculature in humans. Eur J Appl Physiol 2010, 108:845-875.
42. Laurin D., Verreault R., Lindsay J., et al. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 2001, 58:498-504.
43. Strawbridge W.J., Deleger S., Roberts R.E., et al. Physical activity reduces the risk of subsequent depression for older adults. Am J Epidemiol 2002, 156:328-334.
44. Koster A., Penninx B.W., Newman A.B., et al. Lifestyle factors and incident mobility limitation in obese and non-obese older adults. Obesity (Silver Spring) 2007, 15:3122-3132.
45. Lee J.S., Auyeung T.W., Kwok T., et al. Associated factors and health impact of sarcopenia in older chinese men and women: a cross-sectional study. Gerontology 2007, 53:404-410.
46. Eggermont L.H., Milberg W.P., Lipsitz L.A., et al. Physical activity and executive function in aging: the MOBILIZE Boston Study. J Am Geriatr Soc 2009, 57:1750-1756.
47. Teychenne M., Ball K., Salmon J. Physical activity and likelihood of depression in adults: a review. Prev Med 2008, 46:397-411.
48. Andel R., Crowe M., Pedersen N.L., et al. Physical exercise at midlife and risk of dementia three decades later: a population-based study of Swedish twins. J Gerontol A Biol Sci Med Sci 2008, 63:62-66.
49. Ravaglia G., Forti P., Lucicesare A., et al. Physical activity and dementia risk in the elderly: findings from a prospective Italian study. Neurology 2008, 70:1786-1794.
50. Newson R.S., Kemps E.B. Cardiorespiratory fitness as a predictor of successful cognitive ageing. J Clin Exp Neuropsychol 2006, 28:949-967.
51. Erickson K.I., Prakash R.S., Voss M.W., et al. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus 2009, 19:1030-1039.
52. Heyn P., Ottenbacher K.J. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil 2004, 85:1694-1704.
53. Colcombe S., Kramer A.F. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 2003, 14:125-130.
54. Voss M.W., Prakash R.S., Erickson K.I., et al. Plasticity of brain networks in a randomized intervention trial of exercise training in older adults. Front Aging Neurosci 2010, 2.
55. Colcombe S.J., Erickson K.I., Scalf P.E., et al. Aerobic exercise training increases brain volume in aging humans. J Gerontol A Biol Sci Med Sci 2006, 61:1166-1170.
56. Mattson M.P., Maudsley S., Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004, 27:589-594.
57. Tyler W.J., Alonso M., Bramham C.R., et al. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 2002, 9:224-237.
58. Karege F., Perret G., Bondolfi G., et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002, 109:143-148.
59. Connor B., Young D., Yan Q., et al. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 1997, 49:71-81.
60. Zoladz J.A., Pilc A. The effect of physical activity on the brain derived neurotrophic factor: from animal to human studies. J Physiol Pharmacol 2010, 61:533-541.
61. Knaepen K., Goekint M., Heyman E.M., et al. Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sports Med 2010, 40:765-801.
62. Rafnsson S.B., Deary I.J., Smith F.B., et al. Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study. Psychosom Med 2007, 69:425-434.
63. Romero J.R., Beiser A., Seshadri S., et al. Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke 2009, 40:1590-1596.
64. Wakefield D.B., Moscufo N., Guttmann C.R., et al. White matter hyperintensities predict functional decline in voiding, mobility, and cognition in older adults. J Am Geriatr Soc 2010, 58:275-281.
65. Wendell C.R., Zonderman A.B., Metter E.J., et al. Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke 2009, 40:3180-3185.
66. Sheline Y.I., Pieper C.F., Barch D.M., et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 2010, 67:277-285.
67. Santos M., Kovari E., Hof P.R., et al. The impact of vascular burden on late-life depression. Brain Res Rev 2009, 62:19-32.
68. Bian K., Doursout M.F., Murad F. Vascular system: role of nitric oxide in cardiovascular diseases. J Clin Hypertens (Greenwich) 2008, 10:304-310.
69. Endres M., Gertz K., Lindauer U., et al. Mechanisms of stroke protection by physical activity. Ann Neurol 2003, 54:582-590.
70. McAllister R.M., Newcomer S.C., Laughlin M.H. Vascular nitric oxide: effects of exercise training in animals. Appl Physiol Nutr Metab 2008, 33:173-178.
71. Endres M., Laufs U., Liao J.K., et al. Targeting eNOS for stroke protection. Trends Neurosci 2004, 27:283-289.
72. Maeda S., Miyauchi T., Kakiyama T., et al. Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans. Life Sci 2001, 69:1005-1016.
73. Biessels G.J., Staekenborg S., Brunner E., et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
74. Luchsinger J.A., Tang M.X., Shea S., et al. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004, 63:1187-1192.
75. Pasquier F., Boulogne A., Leys D., et al. Diabetes mellitus and dementia. Diabetes Metab 2006, 32:403-414.
76. Sonnen J.A., Larson E.B., Brickell K., et al. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol 2009, 66:315-322.
77. Farris W., Mansourian S., Chang Y., et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003, 100:4162-4167.
78. Freude S., Plum L., Schnitker J., et al. Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. Diabetes 2005, 54:3343-3348.
79. Williams P.T. Association between walking distance and percentiles of body mass index in older and younger men. Br J Sports Med 2008, 42:352-356.
80. Li S., Zhao J.H., Luan J., et al. Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study. PLoS Med 2010, 7.
81. Mortensen L.H., Siegler I.C., Barefoot J.C., et al. Prospective associations between sedentary lifestyle and BMI in midlife. Obesity (Silver Spring) 2006, 14:1462-1471.
82. Petersen L., Schnohr P., Sorensen T.I. Longitudinal study of the long-term relation between physical activity and obesity in adults. Int J Obes Relat Metab Disord 2004, 28:105-112.
83. Villareal D.T., Apovian C.M., Kushner R.F., et al. American Society for Nutrition, NAASO, TOS. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr 2005, 82:923-934.
84. Peeters A., Barendregt J.J., Willekens F., et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003, 138:24-32.
85. Beydoun M.A., Beydoun H.A., Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 2008, 9:204-218.
86. Yan L.L., Daviglus M.L., Liu K., et al. Midlife body mass index and hospitalization and mortality in older age. JAMA 2006, 295:190-198.
87. Blaum C.S., Xue Q.L., Michelon E., et al. The association between obesity and the frailty syndrome in older women: the Women's Health and Aging Studies. J Am Geriatr Soc 2005, 53:927-934.
88. Tanko L.B., Bagger Y.Z., Alexandersen P., et al. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003, 107:1626-1631.
89. Wiklund P., Toss F., Weinehall L., et al. Abdominal and gynoid fat mass are associated with cardiovascular risk factors in men and women. J Clin Endocrinol Metab 2008, 93:4360-4366.
90. Fain J.N., Madan A.K., Hiler M.L., et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145:2273-2282.
91. Rocha V.Z., Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009, 6:399-409.
92. Roubenoff R., Parise H., Payette H.A., et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med 2003, 115:429-435.
93. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
94. Visser M., Pahor M., Taaffe D.R., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002, 57:M326-M332.
95. Ershler W.B. A gripping reality: oxidative stress, inflammation, and the pathway to frailty. J Appl Physiol 2007, 103:3-5.
96. Cawthorn W.P., Sethi J.K. TNF-alpha and adipocyte biology. FEBS Lett 2008, 582:117-131.
97. Rubin D.A., McMurray R.G., Harrell J.S., et al. The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise. Metabolism 2008, 57:683-690.
98. Buford T.W., Anton S.D., Judge A.R., et al. Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev 2010, 9:369-383.
99. McKellar G.E., McCarey D.W., Sattar N., et al. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 2009, 6:410-417.